Real-World evidence of immunotherapy-driven axillary downstaging and surgical de-escalation in triple-negative breast cancer
European Journal of Cancer · 2026-03 · 237 · 116357
DOI: 10.1016/j.ejca.2026.116357 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von L. Pitoni und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pitoni, L., Colmenarejo, A. E., Raber, C. S., Regueira, F. M., Rodriguez-Spiteri, N., Olartecoechea, B., Sobrido, C., Pina, L., Iscar, T., Janeiro, A. L., & Rubio, I. (2026). Real-World evidence of immunotherapy-driven axillary downstaging and surgical de-escalation in triple-negative breast cancer. European Journal of Cancer, 237, 116357. https://doi.org/10.1016/j.ejca.2026.116357
Vancouver
Pitoni L, Colmenarejo AE, Raber CS, Regueira FM, Rodriguez-Spiteri N, Olartecoechea B, et al. Real-World evidence of immunotherapy-driven axillary downstaging and surgical de-escalation in triple-negative breast cancer. European Journal of Cancer. 2026;237:116357. doi:10.1016/j.ejca.2026.116357
BibTeX
@article{Pitoni2026,
author = {Pitoni, L. and Colmenarejo, A.J. Esgueva and Raber, C. Siso and Regueira, F. Martinez and Rodriguez-Spiteri, N. and Olartecoechea, B. and Sobrido, C. and Pina, L.J. and Iscar, T. and Janeiro, A. Lopez and Rubio, I.T.},
title = {Real-World evidence of immunotherapy-driven axillary downstaging and surgical de-escalation in triple-negative breast cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116357},
doi = {10.1016/j.ejca.2026.116357}
}
EUVIMED